Natixis Advisors, L.P. Medpace Holdings, Inc. Transaction History
Natixis Advisors, L.P.
- $63 Billion
- Q2 2025
A detailed history of Natixis Advisors, L.P. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Natixis Advisors, L.P. holds 138,110 shares of MEDP stock, worth $63.1 Million. This represents 0.07% of its overall portfolio holdings.
Number of Shares
138,110
Previous 13,855
896.82%
Holding current value
$63.1 Million
Previous $4.22 Million
926.94%
% of portfolio
0.07%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding MEDP
# of Institutions
649Shares Held
26.8MCall Options Held
54.3KPut Options Held
108K-
Black Rock Inc. New York, NY2.58MShares$1.18 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.39MShares$1.09 Billion0.01% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT946KShares$432 Million1.61% of portfolio
-
Mawer Investment Management Ltd. Calgary, A0817KShares$374 Million1.35% of portfolio
-
State Street Corp Boston, MA707KShares$323 Million0.01% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $14.2B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...